| Drug Name |
Magnesium sulfate heptahydrate |
| Drug ID |
BADD_D01344 |
| Description |
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) |
| Indications and Usage |
Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
A12CC02; V04CC02; B05XA05; D11AX05; A06AD04 |
| DrugBank ID |
DB00653
|
| KEGG ID |
D01108
|
| MeSH ID |
D008278
|
| PubChem ID |
24843
|
| TTD Drug ID |
D02LDN
|
| NDC Product Code |
51927-0086; 51754-1000; 52584-754; 63323-106; 66298-1060; 22431-124; 0264-4400; 0338-1715; 61594-007; 0363-9820; 0264-4206; 61594-004; 63323-108; 67457-554; 0404-9903; 68428-980; 10695-019; 63323-064; 63323-642; 68083-397; 79903-100; 63323-107; 55570-320; 67706-0013; 0338-1708; 61594-003; 61594-006; 61594-010; 64117-259; 66298-1070; 67457-567; 49717-1403; 25021-612; 59779-541; 67706-0012; 71872-7142; 71872-7229; 21291-2000; 67706-0020; 47335-992; 0264-4205; 0338-1719; 61594-011; 67457-553; 68083-396; 0264-4204 |
| UNII |
SK47B8698T
|
| Synonyms |
Magnesium Sulfate | Sulfate, Magnesium | Magnesium Sulfate, Heptahydrate | Heptahydrate Magnesium Sulfate |
